Did you mean: NObel

A whole-genome association study of major determinants for host control of HIV-1

…, S Mallal, J Martinez-Picado, JM Miro, N Obel… - science, 2007 - science.org
Understanding why some people establish and maintain effective control of HIV-1 and
others do not is a priority in the effort to develop new treatments for HIV/AIDS. Using a whole-…

Survival of persons with and without HIV infection in Denmark, 1995–2005

…, J Gerstoft, HT Sørensen, M Væth, N Obel - Annals of internal …, 2007 - acpjournals.org
… We chose 25 years because this was the youngest age group with a sufficient number of
patients (n = 170) being observed. We performed analyses for 3 clinically relevant periods: …

[HTML][HTML] Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies

A Trickey, MT May, JJ Vehreschild, N Obel, MJ Gill… - The lancet HIV, 2017 - thelancet.com
… Our study, based on a large collaboration of cohorts in Europe and North America, found
that substantial declines in mortality for individuals starting ART in 2008–10, compared with …

[HTML][HTML] Common genetic variation and the control of HIV-1 in humans

…, J Dalmau, J Martinez-Picado, JM Miro, N Obel… - PLoS …, 2009 - journals.plos.org
… The most important contributor to population stratification in our Caucasian population is
a North-to-South European ancestry axis. Participants from the USA and Australia are most …

Mortality attributable to smoking among HIV-1–infected individuals: a nationwide, population-based cohort study

…, J Gerstoft, BG Nordestgaard, N Obel - Clinical Infectious …, 2013 - academic.oup.com
… excluded because of injection drug use (n = 567), missing data on smoking status (n = 1497),
or age <35 years at the end of the study period or at censoring (n = 363), leaving 2921 HIV …

[HTML][HTML] Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological …

…, MK Lazanas, C Leport, S Moreno, N Obel… - PLoS …, 2013 - journals.plos.org
… disease versus non-advanced disease stratified by European region of care and time since
presentation; excluding persons with delayed entry into care or unknown first visit date (n = …

[HTML][HTML] Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America

…, C Smith, AC Justice, J Gill, JAC Sterne, N Obel - Aids, 2015 - journals.lww.com
… We hypothesized that these results can be generalized to Western Europe and North
HIV-infected individuals treated in Western Europe and North America. Furthermore, we aimed to …

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a …

…, A De Luca, C Kücherer, N Obel… - The Lancet infectious …, 2011 - thelancet.com
n=10 053, two NRTIs and one NNRTI n=4845, and two NRTIs and one ritonavir-boosted
protease inhibitor n… =4609, and two NRTIs and one ritonavir-boosted protease inhibitor n=2983. …

Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study

N Obel, HF Thomsen, G Kronborg… - Clinical Infectious …, 2007 - academic.oup.com
Background. There are concerns about highly active antiretroviral therapy (HAART) causing
a progressive increase in the risk of ischemic heart disease. We examined this issue in a …

Overexpression of Pectin Methylesterase Inhibitors in Arabidopsis Restricts Fungal Infection by Botrytis cinerea

…, A Raiola, L Camardella, A Giovane, N Obel… - Plant …, 2007 - academic.oup.com
… Data represent the average ± sd of n = 30 independent samples for wild type and n = 20
independent samples for each transformed lines. Ten seedlings were used for each sample. …
Did you mean to search for: NObel